We are live on ! Find out more
Victory Capital Management

Victory Capital Management Portfolio holdings

AUM $178B
1-Year Est. Return 37.23%
This Fund
S&P 500
This Quarter Est. Return
-0.23%
1 Year Est. Return
+37.23%
3 Year Est. Return
+100.22%
5 Year Est. Return
+128.39%
10 Year Est. Return
+575.99%
AUM
$102B
AUM Growth
-$2.04B
Cap. Flow
-$1.16B
Cap. Flow %
-1.13%
Top 10 Hldgs %
10.73%
Holding
2,908
New
180
Increased
1,145
Reduced
1,360
Closed
133

Sector Composition

Rank Sector Weight
1 Technology 17.64%
2 Industrials 13.83%
3 Financials 12.36%
4 Consumer Discretionary 10.78%
5 Healthcare 9.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IVAC
2651
DELISTED
Intevac Inc
IVAC
$55K ﹤0.01%
11,462
-33
-0.3% -$181
EPZM
2652
DELISTED
Epizyme, Inc
EPZM
$55K ﹤0.01%
10,736
-352
-3% -$2.14K
CECO icon
2653
Ceco Environmental
CECO
$4.14B
$53K ﹤0.01%
7,521
-467
-6% -$3.32K
CNVS icon
2654
Cineverse
CNVS
$65.6M
$53K ﹤0.01%
1,057
+116
+12% +$4.09K
LFVN icon
2655
LifeVantage
LFVN
$85.3M
$52K ﹤0.01%
7,650
+221
+3% +$1.63K
RNAC icon
2656
Cartesian Therapeutics
RNAC
$268M
$52K ﹤0.01%
414
-8
-2% -$966
RRD
2657
DELISTED
RR Donnelley & Sons Co.
RRD
$52K ﹤0.01%
10,156
-539
-5% -$2.88K
TCRT icon
2658
Alaunos Therapeutics
TCRT
$4.86M
$51K ﹤0.01%
185
+4
+2% +$1.22K
EDUC icon
2659
Educational Development Corp
EDUC
$11.8M
$48K ﹤0.01%
4,935
-230
-4% -$2.44K
POL
2660
DELISTED
Polished.com Inc.
POL
$48K ﹤0.01%
303
-6
-2% -$904
NMTR
2661
DELISTED
9 Meters Biopharma
NMTR
$48K ﹤0.01%
1,853
-68
-4% -$1.6K
NEXT icon
2662
NextDecade
NEXT
$1.78B
$46K ﹤0.01%
16,721
-994
-6% -$3.13K
IMDX
2663
Insight Molecular Diagnostics
IMDX
$156M
$46K ﹤0.01%
646
+16
+3% +$1.47K
TXMD icon
2664
TherapeuticsMD
TXMD
$24M
$45K ﹤0.01%
1,203
+113
+10% +$5.01K
SPPI
2665
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$45K ﹤0.01%
20,673
-960
-4% -$2.62K
AMPE
2666
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$44K ﹤0.01%
89
-8
-8% -$3.71K
NPKI
2667
NPK International
NPKI
$1.14B
$43K ﹤0.01%
12,983
-261,866
-95% -$740K
BKCC
2668
DELISTED
BlackRock Capital Investment Corporation
BKCC
$43K ﹤0.01%
11,115
-570
-5% -$2.28K
INFI
2669
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$43K ﹤0.01%
12,510
-761
-6% -$2.35K
EGIO
2670
DELISTED
Edgio, Inc. Common Stock
EGIO
$42K ﹤0.01%
442
-17
-4% -$1.79K
STON
2671
DELISTED
StoneMor Inc.
STON
$42K ﹤0.01%
16,994
-850
-5% -$2.18K
NCMI icon
2672
National CineMedia
NCMI
$378M
$40K ﹤0.01%
1,131
+23
+2% +$747
FBIO icon
2673
Fortress Biotech
FBIO
$88.7M
$39K ﹤0.01%
798
+1
+0.1% +$49
MTNB icon
2674
Matinas BioPharma
MTNB
$1.81M
$39K ﹤0.01%
606
-17,807
-97% -$768K
LITS
2675
Lite Strategy Inc
LITS
$30.9M
$38K ﹤0.01%
684
-35
-5% -$1.93K

Similar funds

Victory Capital Management's Q3 2021 Portfolio in Review

As of Q3 2021, Victory Capital Management held 2,908 positions worth $102B, down 2% from $104B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Victory Capital Management's Q3 2021 filing shows 180 new, 1,145 increased, 1,360 reduced and 133 closed positions. Its largest new stake was Stanley Black & Decker, Inc.: 824,973 shares worth $86.8M. The largest sale was Alphabet (Google) Class C, an estimated $243M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 18% a quarter earlier, followed by Industrials and Financials.

  • Victory Capital Management's largest Q3 2021 buy was Stanley Black & Decker, Inc.: 824,973 shares worth $86.8M.
  • Victory Capital Management added most to Newell Brands in Q3 2021, an estimated $214M increase.
  • Victory Capital Management's biggest Q3 2021 reduction was Alphabet (Google) Class C, cutting an estimated $243M.
  • Victory Capital Management fully exited Core Mark Holding Co., Inc. in Q3 2021, selling an estimated $122M.
  • Victory Capital Management's ten largest holdings make up 11% of its $102B portfolio in Q3 2021.
  • Victory Capital Management opened 180 new positions and closed 133 in Q3 2021.
  • Victory Capital Management's portfolio value fell 2% quarter-over-quarter to $102B.

Based on Victory Capital Management's 13F filing for Q3 2021, filed 2 Nov 2021.